Last Modified: December 3, 2002
Selma Schimmel, CEO and founder of Vital Options International, will be joining Dr. Robert Comis, leading national oncologist, President and Chairman, CNCCG, on Wednesday Dec. 4, 2002 12:00 Noon EST, for a clinical trials discussion online. Join the live on-line discussion at either Washington Post Live Online or MSNBC Newsweek Viewpoint. Hosted by Selma Schimmel, breast cancer survivor; CEO & founder of Vital Options International TeleSupport Cancer Network
Feb 27, 2015 - Healthy men should talk to their doctors about taking a 5-alpha reductase inhibitor (5-ARI) to reduce their risk of prostate cancer, according to a joint guideline published online Feb. 24 in the Journal of Clinical Oncology by the American Society of Clinical Oncology and the American Urological Association, and released to coincide with the American Society of Clinical Oncology's Genitourinary Cancers Symposium held Feb. 26 to 28 in Orlando. The guidelines will also appear in the March issue of the Journal of Urology.
Feb 27, 2015